| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Townsend Richard Nolan is a Chief Executive Officer at Lexeo Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $2.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 11, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 55,000 | $16.79 | $923,387.71 | -9.2% | -51.3% | -74.4% | |
| Jun 10, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 5,000 | $17.65 | $88,263.82 | -1.4% | -42.2% | -75.4% | |
| May 13, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 5,000 | $13.22 | $66,093.00 | -2.8% | -11.7% | -79.1% |